Assertio Therapeutics
ASRT
$1.22
Share price
18.45%
Change (1 day)
-80.16%
Change (1 year)
Categories
Operating Margin for Assertio Therapeutics (ASRT)
Operating Margin as of May 2024 (TTM): -0.49%
According to Assertio Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -0.49%. At the end of 2021 the company had an Operating Margin of -0.50%.
Operating Margin history for Assertio Therapeutics from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -0.50% | -98.84% |
| 2020 | -42.83% | -55.82% |
| 2019 | -96.94% | -895.88% |
| 2018 | 12.18% | -144.62% |
| 2017 | -27.30% | 92.93% |
| 2016 | -14.15% | -60.65% |
| 2015 | -35.96% | -165.86% |
| 2014 | 54.59% | 1499.68% |
| 2013 | 3.41% | -110.38% |
| 2012 | -32.89% | -161.5% |
| 2011 | 53.49% | 1009.9% |
| 2010 | 4.82% | -112.63% |
| 2009 | -38.15% | -13.13% |
| 2008 | -43.92% | -157.82% |
| 2007 | 75.95% | -118.33% |
| 2006 | -414.36% | -25.39% |
| 2005 | -555.40% | -95.8% |
| 2004 | -13,217.54% | 341.5% |
| 2003 | -2,993.76% | 74.94% |
| 2002 | -1,711.27% | 338.93% |
| 2001 | -389.88% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | 7,320.41% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | 1,712,379.59% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.